Legal opinion of JunHe Law Firm, Peking, regarding shareholder and actual controller of Sichuan BailiTianheng Pharmaceutical Co., Ltd. increasing their shareholding
Announcement from Sichuan BaiLiTianHeng Pharmaceutical Co., Ltd. regarding the submission of an application to the Hong Kong Stock Exchange for the issuance and listing of overseas listed foreign shares (H shares) and the publication of application materials.
Announcement on the Resolutions of the 13th Meeting of the Fourth Board of Supervisors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Announcement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. regarding the change of board of directors' secretary.
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Fund-raising Management System (Draft)
Sichuan Baili Pharmaceutical Group Related Party Transaction Management System (Draft)
Draft of Working System for Independent Directors of Sichuan Bailitianheng Pharmaceutical Co., Ltd.
Draft of the Rules of Procedure of the Supervisory Board of Sichuan Bai Li Tian Heng Pharmaceutical Co., Ltd.
The Rules of Procedure for the Shareholders' Meeting of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. (Draft)
Draft of the Constitution of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Announcement of the resolutions of the 15th meeting of the fourth board of directors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Statement and Commitment of Nominee for Independent Director of the STAR Market Listed Company (Xiao Geng)
Statement and Commitment of Independent Director Candidate (Xiao Geng) of Star Market Listed Company
The third meeting of the nomination committee of the fourth board of directors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. resolved in 2024.
Shareholder meeting rules of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. (revised in June 2024).
Announcement from Sichuan BaiLi TianHeng Pharmaceutical Co., Ltd. regarding the appointment of a Hong Kong-listed audit firm for H-share issuance and listing.
Announcement on the Planned Issuance of H Shares Stocks and Listing on the Hong Kong Exchange by Sichuan Bai Li Tian Heng Pharmaceutical Co., Ltd.
Information Disclosure Management System (Draft) for Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Investor Relations Activity Schedule (May 22, 2024)
SDIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
No Data